Status:

UNKNOWN

A Study With Peptide Vaccination in Treating Patients With Esophageal Cancer

Lead Sponsor:

University of Yamanashi

Collaborating Sponsors:

Human Genome Center, Institute of Medical Science, University of Tokyo

Conditions:

Esophageal Cancer

Eligibility:

All Genders

20-80 years

Phase:

PHASE2

Brief Summary

The purpose of this study is to evaluate overall survival and immunological monitoring for peptide vaccination therapy using novel cancer testis antigens for locally advanced, recurrent, or metastatic...

Detailed Description

The phase I vaccination study using peptides derived from TTK, LY6K, and IMP-3 for locally advanced, recurrent or metastatic esophageal squamous cell carcinoma (ESCC) who had failed for the standard t...

Eligibility Criteria

Inclusion

  • DISEASE CHARACTERISTICS
  • Locally advanced, recurrent or metastatic esophageal squamous cell carcinoma who had failed for the standard therapy
  • PATIENTS CHARACTERISTICS
  • ECOG performance status 0-2
  • Age≧ 20≦ 80years
  • WBC≥ 2,000/mm³ Platelet count ≥ 75,000/mm³ Total bilirubin ≤ 2.0 x the institutional normal upper limits AST, ALT, ALP ≤ 2.5 x the institutional normal upper limits Creatinine ≤ 1.5 x the institutional normal upper limits
  • No therapy 4 weeks prior to the initiation of the trial
  • Able and willing to give valid written informed consent

Exclusion

  • Pregnancy (women of childbearing potential: Refusal or inability to use effective means of contraception)
  • Breastfeeding
  • Serious bleeding disorder
  • Serious infections requiring antibiotics
  • Concomitant treatment with steroids or immunosuppressing agent
  • Decision of unsuitableness by principal investigator or physician-in-charge

Key Trial Info

Start Date :

November 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 1 2011

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT00995358

Start Date

November 1 2008

End Date

October 1 2011

Last Update

October 15 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

First Department of Surgery, University of Yamanashi

Chūō, Yamanashi, Japan, 409-3898

A Study With Peptide Vaccination in Treating Patients With Esophageal Cancer | DecenTrialz